4.5 Review

Connection Lost, MAM: Errors in ER-Mitochondria Connections in Neurodegenerative Diseases

Journal

BRAIN SCIENCES
Volume 11, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/brainsci11111437

Keywords

mitochondria associated membranes (MAMs); Alzheimer's disease; Huntington's disease; Parkinson's disease; amyotrophic lateral sclerosis

Categories

Ask authors/readers for more resources

Mitochondria associated membranes (MAMs) are important structures that physically and biochemically connect mitochondria with endoplasmic reticulum, playing a crucial role in cellular functions such as Ca2+ homeostasis, proteostasis, mitochondrial bioenergetics, movement, and mitophagy. The increasing number of disease-related proteins and genes associated with MAMs suggests their potential involvement in neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. MAMs have recently gained attention as modulators for ER-mitochondria communication and function, showing promise for future therapeutic discoveries in this rapidly developing field.
Mitochondria associated membranes (MAMs), as the name suggests, are the membranes that physically and biochemically connect mitochondria with endoplasmic reticulum. MAMs not only structurally but also functionally connect these two important organelles within the cell which were previously thought to exist independently. There are multiple points of communication between ER-mitochondria and MAMs play an important role in both ER and mitochondria functions such as Ca2+ homeostasis, proteostasis, mitochondrial bioenergetics, movement, and mitophagy. The number of disease-related proteins and genes being associated with MAMs has been continually on the rise since its discovery. There is an overwhelming overlap between the biochemical functions of MAMs and processes affected in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). Thus, MAMs have received well-deserving and much delayed attention as modulators for ER-mitochondria communication and function. This review briefly discusses the recent progress made in this now fast developing field full of promise for very exciting future therapeutic discoveries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available